NCT05427162View on ClinicalTrials.gov

A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

December 5, 2023

Study Completion Date

December 5, 2023

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Prostacyclin Receptor Agonist

Prostacyclin receptor agonist will be administered.

Trial Locations (1)

85283

Celerion, Tempe

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY